Catib, Cassandra .

HRN: 26-18-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/06/2024
11/13/2024
IV
350
Q8h
Amoebiasis
Waiting Final Action 
11/07/2024
CEFUROXIME 1.5GM (VIAL)
11/07/2024
11/14/2024
IV
1 G
Q8h
UTI
Waiting Final Action 
11/09/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/09/2024
11/16/2024
PO
10ml
Tid
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: